Macular Oedema in Idiopathic Macular Telangiectasia Type 1 Responsive to Aflibercept but Not Bevacizumab
Figure 2
(a)-(b) After 3 monthly bevacizumab treatments, (c)-(d) after laser photogaoculation treatment, (e)-(f) after 4 months of aflibercept treatment, (g)-(h) after 4 months without treatment, and (i)-(j) after 4 weeks of aflibercept injection.